Literature DB >> 11008263

Moyamoya syndrome with protein S deficiency.

D Akgün1, S YiLmaz, N Senbil, B Aslan, Y Y Gürer.   

Abstract

Moyamoya disease is a cerebrovascular disease with progressive occlusion of both internal carotid arteries and of their branches and formation of a new vascular network at the base of the brain. Because of the angiographic appearance, it is named as moyamoya. The clinical features are cerebral ischaemia, recurrent transient ischaemic attacks, sensorimotor paralysis, convulsions and migraine-like headaches. A 10-year-old child who acutely developed hemiparesis, weakness and aphasia was found to have moyamoya disease and heterozygous protein S deficiency. This case shows us that during the thromboembolic events the coexistence of protein S deficiency and moyamoya should be investigated. Copyright 2000 European Paediatric Neurology Society.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11008263     DOI: 10.1053/ejpn.2000.0298

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  5 in total

1.  Familial moyamoya disease in two Turkish siblings with same polymorphism in RNF213 gene but different clinical features.

Authors:  Ayşe Kaçar Bayram; Ebru Yilmaz; Huseyin Per; Masaki Ito; Haruto Uchino; Selim Doganay; Kiyohiro Houkin; Ekrem Unal
Journal:  Childs Nerv Syst       Date:  2015-08-16       Impact factor: 1.475

2.  Moyamoya disease and Down syndrome.

Authors:  Muferet Erguven; Murat Deveci; Tahsin Turgut
Journal:  Indian J Pediatr       Date:  2005-08       Impact factor: 1.967

3.  Moyamoya-like vasculopathy (moyamoya syndrome) in children.

Authors:  Peter Horn; Stefan Pfister; Eva Bueltmann; Peter Vajkoczy; Peter Schmiedek
Journal:  Childs Nerv Syst       Date:  2004-05-01       Impact factor: 1.475

4.  Protein S Deficiency and an Adult Case with Moyamoya Syndrome that Presented with Primary Intraventricular Haemorrhage.

Authors:  Betül Cevik; Berat Acu; Dürdane Aksoy; Semiha Kurt
Journal:  Balkan Med J       Date:  2014-06-01       Impact factor: 2.021

5.  Clinical features, prothrombotic risk factors, and long-term follow-up of eight pediatric Moyamoya patients.

Authors:  Burak Tatlı; Barış Ekici; Altay Sencer; Serra Sencer; Kubilay Aydın; Nur Aydınlı; Mine Calışkan; Meral Ozmen; Talat Kırış
Journal:  J Clin Neurol       Date:  2012-06-29       Impact factor: 3.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.